FI870421A - Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi - Google Patents

Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI870421A
FI870421A FI870421A FI870421A FI870421A FI 870421 A FI870421 A FI 870421A FI 870421 A FI870421 A FI 870421A FI 870421 A FI870421 A FI 870421A FI 870421 A FI870421 A FI 870421A
Authority
FI
Finland
Prior art keywords
triazine
dihydro
substituted phenyl
compounds
preparation
Prior art date
Application number
FI870421A
Other languages
English (en)
Swedish (sv)
Other versions
FI94634C (fi
FI870421A0 (fi
FI94634B (fi
Inventor
Gustaaf Maria Boeckx
Alfons Herman Marg Raeymaekers
Victor Sipido
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI870421A0 publication Critical patent/FI870421A0/fi
Publication of FI870421A publication Critical patent/FI870421A/fi
Priority to FI923914A priority Critical patent/FI923914A/fi
Application granted granted Critical
Publication of FI94634B publication Critical patent/FI94634B/fi
Publication of FI94634C publication Critical patent/FI94634C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI870421A 1986-01-30 1987-01-30 Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi FI94634C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI923914A FI923914A (fi) 1986-01-30 1992-09-01 Foerfarande foer framstaellning av 2-(substituerad fenyl)-1,2,4-triazin-3,5(2h,4h)-dionderivat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8602342 1986-01-30
GB868602342A GB8602342D0 (en) 1986-01-30 1986-01-30 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Publications (4)

Publication Number Publication Date
FI870421A0 FI870421A0 (fi) 1987-01-30
FI870421A true FI870421A (fi) 1987-07-31
FI94634B FI94634B (fi) 1995-06-30
FI94634C FI94634C (fi) 1995-10-10

Family

ID=10592258

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870421A FI94634C (fi) 1986-01-30 1987-01-30 Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (3) US4767760A (fi)
EP (1) EP0232932B1 (fi)
JP (2) JPH0813806B2 (fi)
CN (1) CN1017049B (fi)
AT (1) ATE59644T1 (fi)
AU (1) AU586731B2 (fi)
CA (2) CA1288772C (fi)
DE (1) DE3766839D1 (fi)
DK (2) DK169032B1 (fi)
ES (1) ES2031876T3 (fi)
FI (1) FI94634C (fi)
GB (1) GB8602342D0 (fi)
GR (1) GR3001392T3 (fi)
IE (1) IE59510B1 (fi)
IL (1) IL81421A (fi)
NO (1) NO172690C (fi)
NZ (1) NZ218973A (fi)
PT (1) PT84218B (fi)
RU (1) RU2017736C1 (fi)
SU (1) SU1595339A3 (fi)
ZA (1) ZA87672B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097779A (en) * 1976-04-05 1978-06-27 Gte Sylvania Incorporated Fluorescent lamp containing a cathode heater circuit disconnect device
US4156831A (en) * 1978-05-24 1979-05-29 Gte Sylvania Incorporated Fluorescent lamp having heater circuit disconnect device
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
DE3826058A1 (de) * 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US5070091A (en) * 1989-01-09 1991-12-03 Bayer Aktiengesellschaft Substituted 1,2,4-triazinediones useful against protozoa in insects
EP0377903A3 (de) * 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) * 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
CA2012004A1 (en) * 1989-03-15 1990-09-15 Frank Ellis Chemical compounds
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
DE4120138A1 (de) * 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
US5994355A (en) * 1993-10-15 1999-11-30 Takeda Chemical Industries, Ltd. 1, 2, 4-Triazin-3-one derivatives, production and use thereof
DE69615601T2 (de) * 1995-04-14 2002-07-11 Takeda Schering-Plough Animal Health K.K., Osaka Verfahren zur Herstellung von Triazinderivate
US5747476A (en) 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
KR19980019182A (ko) * 1996-08-30 1998-06-05 다께다 구니오 1,2,4-트리아진-3,5-디온 유도체, 그의 생성법 및 그의 용도(1,2,4-triazine-3,5-dione derivatives, their production a nd use thereof)
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
PL337947A1 (en) * 1997-07-10 2000-09-11 Janssen Pharmaceutica Nv Il-5 inhibiting derivatives of 6-azauracil
NZ501627A (en) 1997-07-10 2002-02-01 Janssen Pharmaceutica Nv 3,5-dioxo-2(3H)-triazine derivatives substituted by 4-(phenylmethyl)phenyl useful as IL-5 inhibitors
US6867207B2 (en) * 1997-07-10 2005-03-15 Janssen Pharmaceutica N.V. IL-5 inhibiting 6-azauracil derivatives
US6294536B1 (en) 1997-08-29 2001-09-25 Takeda Schering-Plough Animal Health K.K. Triazine derivatives, their production and use
WO2000006172A1 (en) * 1998-07-27 2000-02-10 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
MXPA01003542A (es) * 1998-10-08 2002-09-18 New Ace Res Company Composiciones y metodos nuevos para la prevencion y tratamiento de enfermedad causada por protozoarios.
ATE365723T1 (de) * 1998-12-18 2007-07-15 Janssen Pharmaceutica Nv Il-5 hemmende 6-uracilderivate
PL353475A1 (en) 1999-08-06 2003-11-17 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
PA8591801A1 (es) * 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
GB0622472D0 (en) * 2006-11-10 2006-12-20 Addex Pharmaceuticals Sa Novel heterocyclic derivatives
CN107746390B (zh) * 2017-11-21 2021-03-16 连云港市亚晖医药化工有限公司 抗球虫药地克珠利的制备方法
CN113999139A (zh) * 2021-12-03 2022-02-01 杭州臻峰科技有限公司 制备2，6-二氯-α-（4-氯代苯基） -4-硝基苯乙腈的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912723A (en) * 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3905971A (en) * 1971-03-29 1975-09-16 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
GB1448696A (en) * 1973-05-29 1976-09-08 Pfizer 2-phqnyl-astriazine-3,4-2h,4h-diones
DE3408924A1 (de) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt Substituierte 2-phenyl-hexahydro-1,2,4-triazin-3,5-dione, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
CA1244024A (en) * 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Also Published As

Publication number Publication date
NO172690C (no) 1993-08-25
JP2622510B2 (ja) 1997-06-18
NO870378L (no) 1987-07-31
US4952570A (en) 1990-08-28
US4912106A (en) 1990-03-27
AU586731B2 (en) 1989-07-20
DK65193A (da) 1993-06-04
JPS62190174A (ja) 1987-08-20
DK169032B1 (da) 1994-08-01
ES2031876T3 (es) 1993-01-01
NO172690B (no) 1993-05-18
US4767760A (en) 1988-08-30
CN1017049B (zh) 1992-06-17
PT84218A (en) 1987-02-01
IL81421A (en) 1991-11-21
ZA87672B (en) 1988-09-28
DK65193D0 (da) 1993-06-04
CA1288772C (en) 1991-09-10
DE3766839D1 (de) 1991-02-07
CN87100531A (zh) 1987-09-02
FI94634C (fi) 1995-10-10
IE59510B1 (en) 1994-03-09
FI870421A0 (fi) 1987-01-30
FI94634B (fi) 1995-06-30
IL81421A0 (en) 1987-08-31
NO870378D0 (no) 1987-01-29
SU1595339A3 (ru) 1990-09-23
GR3001392T3 (en) 1992-09-11
IE870231L (en) 1987-07-30
EP0232932B1 (en) 1991-01-02
RU2017736C1 (ru) 1994-08-15
NZ218973A (en) 1988-10-28
CA1302411C (en) 1992-06-02
JPH07285949A (ja) 1995-10-31
DK48187D0 (da) 1987-01-29
JPH0813806B2 (ja) 1996-02-14
DK48187A (da) 1987-07-31
EP0232932A1 (en) 1987-08-19
ATE59644T1 (de) 1991-01-15
PT84218B (pt) 1989-07-31
GB8602342D0 (en) 1986-03-05
AU6813487A (en) 1987-08-06

Similar Documents

Publication Publication Date Title
FI870421A (fi) Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi
ES2055860T3 (es) Derivados 2-aminopirimidinona.
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
KR960009422B1 (en) 4-(ardylamino)piperidinebutanamide derivatives
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.